Xenon Pharmaceuticals (XENE) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts17

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$58.65

Median Target+29.68%

$76.06

Potential upside vs current price

DCF Value-95.84%

$2.44

Potential downside vs current price

Current Stock Price

$58.65

Median Target+29.68%

$76.06

Potential upside vs current price

DCF Value-95.84%

$2.44

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts17

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$58.65

Median Target+29.68%

$76.06

Potential upside vs current price

DCF Value-95.84%

$2.44

Potential downside vs current price

Current Stock Price

$58.65

Median Target+29.68%

$76.06

Potential upside vs current price

DCF Value-95.84%

$2.44

Potential downside vs current price

Xenon Pharmaceuticals Inc.